MedPath

Study on the mechanism of Qingchangxiaopi Decoction and UC large intestine damp-heat syndrome from the activation of LPDC through TLR5-IRF4 pathway to mediate intestinal inflammatio

Phase 1
Not yet recruiting
Conditions
lcerative Colitis
Registration Number
ITMCTR2200005909
Lead Sponsor
Dongguan Hospital of Guangzhou University of Chinese Medinine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria

?The healthy subjects were inquired about medical history and physical examination, excluded cardiovascular and cerebrovascular diseases, diabetes, hypertension, hyperlipidemia and other medical history, and excluded intestinal organic diseases.
?UC patients who meet the diagnostic criteria;
?Meet the criteria for UC in the light to moderate activity period;
?Those who signed the informed consent.

Exclusion Criteria

?Patients with severe heart, liver, kidney and other major organ diseases, hematopoietic system, nervous system or mental diseases;
?Patients with serious complications such as local stricture, toxic megacolon, intestinal obstruction, colon cancer, rectal cancer, intestinal perforation and anal disease;
?Reluctance to sign informed consent and collaborators.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.